Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα

Overview of attention for article published in Frontiers in Pharmacology, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 5 X users

video: 2 YouTube creators

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X YouTube Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 38,867 followers.

@Thomas_Banacek @jonathanstea @psychunseen https://t.co/zdKhSTRNt9

15 Jun 2023

Reply Repost Favourite

ある時、以下を発見 Arctigenin(ARC)は,C/EBPαおよびPPARαによるgankyrinの発現を阻害することにより,肝臓癌の腫瘍形成を阻害 (注：gankyrinは肝細胞癌の早期および肝細胞癌において過剰発現する癌蛋白質) https://t.co/8omkbjbPVE 題名を読んで,「転写活性因子なのに、gankyrinの発現を阻害」？？

20 May 2018

Reply Repost Favourite

RT @FrontPharmacol: Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα https://t.co/AYqe…

29 Mar 2018

Reply Repost Favourite

RT @FrontPharmacol: Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα https://t.co/AYqe…

28 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.